Background and aims: Human mutL homologl (MLH1) works coordinately in sequential steps to initiate repair of DNA mismatches, and aberrant MLH1 expression is related to spermatogenetic malfunction. In the present study, MLH1 expression in patients with azoospermia was investigated, and moderating effects of miR-188-3p on MLH1 expression and spermatogenesis were identified.
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| INTRODUCTION
About 15-20% of couples of childbearing age in China suffer from infertility, with male-factor infertility accounting for 50% and female-factor infertility accounting for 50% respectively. The incidence of infertility is increasing, and it has become a global health problem. Azoospermia, the medical condition of a man not having any measurable level of spermatozoa in his semen, is a very important contributor to male infertility. In recent years, many new techniques, including spermatogonial stem cell transplantation, testis tissue transplantation, induced pluripotent stem cell and gene therapy, have emerged. Testicular sperm extraction technology and intracytoplasmic sperm injection (ICSI) have also been improved, increasing the chances for men to father a child naturally. very critical in meiosis and determines its success or failure. 2 Studies have confirmed that the disorder of meiosis and meiotic recombination defects can lead to the male aspermia and result in infertility. 3 Human mutL homolog l (MLH1) is one component of DNA mismatch repair (MMR) proteins that work coordinately in sequential steps to initiate repair of DNA mismatches. In addition, antibodies against MLH1 are used to identify recombination sites in SCs. It has been established that the location and number of MLH1 foci are important indicators for meiotic recombination. 4, 5 Aberrant numbers and distribution of MLH1 foci are observed in the spermatocyte and spermatozoa of patients with azoospermia. 6, 7 However, few and limited studies have established the determination of testicular MLH1 expression in male infertility. The role of MLH1 expression in spermatogenesis and its potential molecular mechanisms also remain to be fully illustrated.
MicroRNA (miRNA) is a kind of non-coding RNA that participates in the regulation of gene expression through translational repression, mRNA cleavage and deadenylation. miRNA interacts with its mRNA targets by base pairing and down-regulated mRNA expression. 8 Emerging evidence has demonstrated that miRNAs play an important role in various human diseases and physiological processes. 9, 10 More than one hundred miRNAs have been identified in mammalian testes. 11, 12 It has been indicated that miRNA expression of spermatogenic cells is altered in different developmental stages, suggesting that miRNAs may mediate the development of spermatogenic cells and contribute to the spermatogenesis and to male infertility. The expression of miR-188-3p is enriched in human testis-specific cells, including the spermatogonium and spermatocyte, and it can also be detected in the meiosis phase of mice cells. 13 As reported in the TargetScan and MicroCosm database, MLH1 is a potential target of miR-188-3p. However, the role of miR-188-3p in MLH1 regulation and spermatogenesis is not clear.
In the present study, the expression of MLH1 and miR-188-3p in testicular spermatogenic cells in patients with azoospermia were investigated and the relationship between these two molecules was also discussed.
| MATERIALS AND METHODS
| Subjects
In this study, eight healthy testicular tissues were collected from subjects with normal spermatogenic function who were undergoing surgical removal of testicular tissue for prostate cancer. A total of 16 patients with azoospermia were also included in this study. Eight patients were diagnosed as having obstructive azoospermia (OA), and eight patients were diagnosed as having non-obstructive azoospermia (NOA). Testicular tissues were collected from azoospermia patients undergoing testicular biopsy or ICSI. Informed consent was obtained from all participants, and this study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University and carried out in accordance with the guideline of the ethical management. 
| Cell culture
| Animals and treatment
Male Kunming mice (20-25 g), purchased from Laboratory Animal 
| Immunohistochemical staining
The conventional paraffin section and immunohistochemical staining were performed to detect the expression of MLH1 in spermatogenic cells of testicular tissue from healthy subjects and from patients with azoospermia.
| Real-time PCR
TRIzol reagent (Invitrogen) was used to extract the total RNA from spermatogenic cells of testicular tissue and NT-2 cells according to the manufacturer's instructions. Complementary DNA (cDNA) was reverse-transcribed by a PrimeScript RT reagent Kit (TaKaRa, Otsu, Japan). Then, the real-time PCR was performed on the ABI 7500HT Fast
Real-Time PCR System using QuantiNova SYBR Green PCR (Qiagen, Hilden, Germany) for the quantification of MLH1 and miR-188-3p
expression. The specific primers are shown in Table 1 . The relative expression of MLH1 and miR-188-3p were calculated with 2 -△△Ct , with GAPDH and U6 acting as internal controls.
| Western blot
Total protein was extracted from spermatogenic cells of testicular tissue and NTERA-2 cells using a lysis buffer containing 1% protease inhibition. After centrifugation, the supernatant was kept and used to detect the protein concentration using the bull serum albumin (BSA)
method. The equal amount of protein in each sample was electrophoresed on 10% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane.
After blocking with non-fat dry 5% milk in Tris-HCl-buffered saline, the 
| Chromatin immunoprecipitation assay
The histone acetylation of miR-188-3p promoter was assessed was used to detect the relative luciferase activity of MLH1 3′UTR.
| Flow cytometry
The apoptosis rate of spermatogenic cells was determined by flow cytometry with Annexin V/PI staining. In brief, we adjusted the cell concentration to 1×10 6 /mL and centrifuged at 1000 g for 5 minutes. We discarded the supernatant, washed cells with PBS buffer, and centrifuged at 1000 g for 5 minutes. After repeating this step twice, we re-suspended the cells with 100 μL binding buffer and added 20 μL Annexin V-FITC (20 μg/mL) for 15 minutes on ice in the dark. We transferred the mixture to test tube and added with 400 μL PBS buffer. The 1 μL PI (50 μg/mL) was then incubated with the mixture, and we immediately performed the determination with flow cytometry. The apoptosis rate was calculated with the software.
| Statistical analysis
All statistical analyses were conducted with statistical software SpSS 18.0. All data were expressed as mean ± SD. A one-way ANOVA with Turkey's multiple comparison tests was used to analyse the mean with more than two groups. Differences between the two groups were analysed by an independent Student's t-test. The P value <.05 was considered a significant difference.
| RESULTS
| Increased testicular MLH1 expression in patients with azoospermia
The MLH1 expression was first investigated in the testicular spermatogenic cells of patients with azoospermia. As shown Fig. 1a,b 
| Decreased testicular miR-188-3p expression in patients with azoospermia
Previous study reported that miR-188-3p expression was enriched in spermatogonium and spermatocyte, 13 and we found that MLH1 had the complementary sequences with miR-188-3p using bioinformatics soft. To illustrate the potential mechanism of the aberrant MLH1
in patients with azoospermia, the miR-188-3p expression was also evaluated. The results showed that miR-188-3p was markedly downregulated in testicular spermatogenic cells of NOA and OA patients (P<.01, Fig. 2 ), suggesting a potential role of miR-188-3p in spermatogenesis process.
| Decreased histone acetylation level of miR-188-3p promoter in patients with azoospermia
Whether epigenetic modification of miR-188-3p promoter contributes to the decreased miR-188-3p expression was then investigated.
It was observed that H3 and H4 histone acetylation levels of miR-188-3p promoter were significantly decreased in testicular spermatogenic cells of the NOA and OA groups (P<.01, Fig. 3a,b) , indicating the alteration of histone acetylation might cause the decrease of miR-188-3p expression in azoospermia.
| HDAC1 contributes to the regulation of miR-188-3p expression
In vitro experiments were performed to further confirm whether histone acetylation participates in the alteration of miR-188-3p expression in azoospermia. It showed that the miR-188-3p expression level was increased more than 5-fold by the incubation of histone deacetylase inhibitor TSA at the concentrations of 100 and 200 nmol/L (Fig. 4a) .
We then transfected Ad-HDAC1/2 or si-HDAC1/2 into NTERA-2 cells for overexpressing or inhibiting HDAC1/2 expression (Fig. 4b) .
Overexpressed HDAC1, but not HDAC2, contributed to the significant decrease of H3 and H4 histone acetylation levels in miR-188-3p
promoter, while the inhibition of HDAC1, but not HDAC2, led to their significant increase (Fig. 4c) . In addition, only HDAC1 overexpression or inhibition caused the alteration of miR-188-3p expression (Fig. 4d) .
| miR-188-3p targets MLH1 and regulates its expression
As reported in the TargetScan and MicroCosm database, MLH1 is a potential target of miR-188-3p (Fig. 5a) . The relationship between miR-188-3p and MLH1 was then further discussed. The results
showed that miR-188-3p mimic significantly decreased the 3′UTR luciferase activity of MLH1 and down-regulated MLH1 expression in mRNA and protein levels (Fig. 5b) . miR-188-3p inhibitor had the opposite effects (Fig. 5c) . These experiments confirmed that miR-188-3p targets MLH1 and participates in regulating its expression.
| Down-regulation of miR-188-3p increased MLH1 expression in vivo
To further investigate the role of miR-188-3p in spermatogenesis in vivo, miR-188-3p inhibitor was injected into testis of mice. Real-time PCR confirmed that miR-188-3p expression was significantly inhibited by miR-188-3p inhibitor 72 hours after injection (Fig. 6a) . The MLH1 protein expression was also evaluated, and the result showed that MLH1 expression was up-regulated by miR-188-3p inhibitor in testicular tissue (Fig. 6b ).
| miR-188-3p affected spermatogenic cells apoptosis of mice through mediating MLH1
To further clarify the role of miR-188-3p in spermatogenic cells apoptosis in vivo, mouse experiments with the treatment of miR-188-3p inhibitor was then investigated. The results demonstrated that the cell apoptosis rate was significantly elevated by miR-188-3p inhibitor, suggesting miR-188-3p participates in the process of spermatogenic cells apoptosis. However, the increased apoptosis rate induced by miR-188-3p inhibitor was reversed by si-MLH1 (Fig. 7a) . We also observed that si-MLH1 reversed the increased expression of apoptosis-related proteins cleavedcaspase-3 and cleaved-PARP1 induced by miR-188-3p inhibitor (Fig. 7b) . The apoptosis of spermatogenic cells was also evaluated after the treatment of Ad-MLH1, and the results found that Ad-MLH1 contributed to the significant increase of apoptosis rate and cleaved-caspase-3 and cleaved-PARP1 expression (Fig. 7c,d ).
These data indicate that miR-188-3p participates in modulating spermatogenic cells apoptosis, probably through regulation of MLH1 expression.
| DISCUSSION
Azoospermia is identified in 15% of infertile men and can be classified as OA and NOA. Spermatogenesis is the process of producing spermatozoa from the primordial germ cells and occurs in the seminiferous epithelium of the testis seminiferous tubule. may cause DNA base pair mismatch and lead to spermatogenetic malfunction. 17, 18 Animal experiments with defective MLH1 shows that the process of spermatocyte meiosis is stopped and cannot enter into the pachytene stage, leading to the abnormal synapsis of homologous chromosomes and absence of spermatogenesis.
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No production of spermatozoa is observed in mice with the mutation of MLH1. 20 Previous studies have shown that testicular MLH1 expression was decreased in patients with spermatogenetic malfunction. 21 To our surprise, this study showed that the MLH1 expression in the mRNA level was significantly higher in patients with azoospermia than that noted in control subjects, with the NOA group having an even higher MLH1 expression level than that in the OA group. Western blot and immunohistochemical staining also demonstrated that the MLH1 protein level was higher in testicular spermatogenic cells of patients with azoospermia than in the control group, confirming our results were reliable. This study indicated that overexpression of MLH1 might be a critical factor for the spermatogenesis dysfunction. Although our result is inconsistent with prior F I G U R E 2 miR-188-3p expression in testicular spermatogenic cells of healthy subjects and patients with azoospermia. NOA (n=8), non-obstructive azoospermia; OA (n=8), obstructive azoospermia. ** vs control, P<.01 miRNA has been widely considered to be a regulator of gene expression in various biological processes. In the present study, we found that testicular miR-188-3p expression, which is enriched in human testis-specific cells, was lower in patients with azoospermia than in control subjects, suggesting miR-188-3p might be re- PTBP2 is initially identified as an alternative splicing factor mainly expressed in neurons and testis. It has been found that PTBP2 stabilizes the germ cell-specific phosphoglycerate kinase 2 mRNA by binding to a sequence in its 3′UTR. 23 Therefore, PTBP2 is another potential pathway that is regulated by miR-188-3p and implicated in spermatogenesis.
The mechanism of miR-188 expression alteration in azoospermia was also investigated in this study. The results showed that the decrease of H3 and H4 histone acetylation level in miR-188-3p acts as a metastasis regulator in some cancers. 25, 26 It is also involved in the processes of myocardial infarction, Alzheimer's disease, cardiac remodelling, dendritic plasticity and synaptic transmission. [27] [28] [29] [30] However, the knowledge of the potential mechanisms of miR-188-3p
in various physiological processes is limited and remains a topic requiring further studies.
In summary, the main findings of this study demonstrated that testicular MLH1 expression in mRNA and protein levels were significantly up-regulated and miR-188-3p was significantly downregulated in patients with azoospermia. MiR-188-3p targeted 3′UTR
of MLH1 and regulated its expression, contributing to the abnormal 
